Bruker Corporation
Financials
Valuation Metrics
Bruker Corporation's Market Cap is $8.48B. At end of 2025 it was $7.16B. Ranked #979 of 3,118 in US market (top 31%), #313 of 1,474 on NASDAQ (top 21%), #75 of 203 in Health Care Equipment & Services (top 37%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $8.48B | US#979/3,118 Sec#75/203 |
| Revenue | $3.50B | US#1,085/3,118 Sec#64/203 |
| Net Income | $-71M | US—/3,118 Sec—/203 |
| Total Assets | $6.05B | US#1,299/3,118 Sec#58/203 |
| Net Assets | $2.40B | US#1,115/3,118 Sec#59/203 |
| Employees | 11,085 | US#807/3,118 Sec#61/203 |
| Value | ||
| P/B | 3.53x | US#1,967/3,118 Sec#110/203 |
| P/S | 2.42x | US#1,498/3,118 Sec#103/203 |
| EV/EBITDA | 41.21x | US#2,326/3,118 Sec#128/203 |
| FCF Yield | 1.11% | US#2,156/3,118 Sec#130/203 |
| Profitability | ||
| ROE | -2.97% | US#2,207/3,118 Sec#123/203 |
| ROA | -1.18% | US#2,313/3,118 Sec#128/203 |
| Op. Margin | 3.61% | US#2,092/3,118 Sec#117/203 |
| Revenue Growth | 1.65% | US#2,073/3,118 Sec#157/203 |
| Earnings Growth | -189.45% | US#1,930/3,118 Sec#100/203 |
| Financial Health | ||
| Debt Ratio | 151.40% | US#1,504/3,118 Sec#134/203 |
| Total Debt | $1.92B | US#1,183/3,118 Sec#60/203 |
| FCF | $94M | US#1,753/3,118 Sec#105/203 |
| Cash | $185M | US#1,790/3,118 Sec#109/203 |
| Current Ratio | 1.85x | US#1,324/3,118 Sec#117/203 |
| Net Debt/EBITDA | 6.99x | US#2,244/3,118 Sec#135/203 |
| Dividend | ||
| Div. Yield | 0.39% | US#1,581/3,118 Sec#46/203 |
| Div. Growth | -25.90% | US—/3,118 Sec—/203 |
| Performance | ||
| 1Y Return | 43.14% | US#411/3,118 Sec#44/203 |
| 1M Return | -11.95% | US#2,529/3,118 Sec#180/203 |
| From 52W High | -16.87% | US#1,152/3,118 Sec#94/203 |
| 1Y MDD | -39.85% | US#1,924/3,118 Sec#120/203 |
| Trading | ||
| Volume | 1,572,539 shares | US#1,121/3,118 Sec#62/203 |
| Trading Value | $88M | US#938/3,118 Sec#72/203 |
| Per Share | ||
| EPS | $-0.47 | US—/3,118 Sec—/203 |
| BPS | $15.77 | US#1,475/3,118 Sec#81/203 |
Company Info
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.